日本Kaneka携还原型辅酶Q10首秀进博会，押注中国健康消费蓝海

Core Insights - Kaneka's participation in the China International Import Expo (CIIE) is a strategic move to align with China's "Healthy China 2030" initiative and tap into the growing health market in China [2][10] - The company aims to position itself not just as a raw material supplier but as a "value partner" for Chinese brands, providing comprehensive support in product development and market education [3][8] Company Strategy - Kaneka has over 45 years of research and development experience in coenzyme Q10, with more than 100 scientific studies and over 80 global patents backing its products [1][2] - The company recognizes the rapid upgrade of China's health consumption market and sees it as a core driver for global business growth [2][6] Product Offering - Kaneka's reduced form of coenzyme Q10 is produced using advanced Japanese fermentation technology, achieving global leadership in purity, stability, and bioavailability [3][4] - This product has a bioavailability that is 3-8 times higher than that of regular coenzyme Q10, allowing for direct absorption without conversion in the body [3][9] Quality Control - Kaneka maintains a stringent quality control system, ensuring that every batch of raw materials exceeds industry standards through scientific testing and third-party verification [4][7] - The company emphasizes consistency in quality, regardless of production scale, which has earned it the trust of over a thousand global brands [4][7] Market Education - Kaneka aims to educate the Chinese market about mitochondrial health, which is currently not widely recognized, by collaborating with medical professionals and social media influencers [5][10] - The company draws parallels to the rise in awareness of gut health over the past decade, hoping to make mitochondrial health a core concept among Chinese consumers [5][6] Target Demographics - The primary consumer group for Kaneka's coenzyme Q10 in China includes middle-aged and elderly individuals focused on cardiovascular health and energy metabolism [6][10] - There is also a growing segment of female consumers interested in reproductive health and skin improvement, indicating a broad market potential [6][10] Competitive Positioning - Compared to mature markets, Chinese consumers prioritize scientific evidence and brand reputation when selecting health products, aligning with Kaneka's product philosophy [7][10] - Kaneka plans to tailor its product solutions to meet local consumer needs while continuing to promote the benefits of its coenzyme Q10 [7][10] Future Directions - Kaneka sees significant potential in the mitochondrial health sector and aims to innovate continuously, exploring new applications for its coenzyme Q10 [9][10] - The company is committed to collaborating with global research institutions to expand its product development directions and enhance its market offerings [9][10]